Logo image of MANH

MANHATTAN ASSOCIATES INC (MANH) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MANH - US5627501092 - Common Stock

174.87 USD
+0.63 (+0.36%)
Last: 12/10/2025, 7:02:33 PM
174.87 USD
0 (0%)
After Hours: 12/10/2025, 7:02:33 PM
Fundamental Rating

7

MANH gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 280 industry peers in the Software industry. MANH gets an excellent profitability rating and is at the same time showing great financial health properties. While showing a medium growth rate, MANH is valued expensive at the moment. With these ratings, MANH could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year MANH was profitable.
In the past year MANH had a positive cash flow from operations.
MANH had positive earnings in each of the past 5 years.
In the past 5 years MANH always reported a positive cash flow from operatings.
MANH Yearly Net Income VS EBIT VS OCF VS FCFMANH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

MANH has a Return On Assets of 28.10%. This is amongst the best in the industry. MANH outperforms 97.50% of its industry peers.
Looking at the Return On Equity, with a value of 69.86%, MANH belongs to the top of the industry, outperforming 97.86% of the companies in the same industry.
The Return On Invested Capital of MANH (61.70%) is better than 99.64% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MANH is significantly above the industry average of 10.98%.
The last Return On Invested Capital (61.70%) for MANH is above the 3 year average (55.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 28.1%
ROE 69.86%
ROIC 61.7%
ROA(3y)25.89%
ROA(5y)23.38%
ROE(3y)64.44%
ROE(5y)55.45%
ROIC(3y)55.23%
ROIC(5y)47.73%
MANH Yearly ROA, ROE, ROICMANH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

Looking at the Profit Margin, with a value of 20.25%, MANH belongs to the top of the industry, outperforming 84.64% of the companies in the same industry.
MANH's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 25.91%, MANH belongs to the best of the industry, outperforming 90.36% of the companies in the same industry.
MANH's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 56.54%, MANH is doing worse than 64.29% of the companies in the same industry.
MANH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.91%
PM (TTM) 20.25%
GM 56.54%
OM growth 3Y7.44%
OM growth 5Y6%
PM growth 3Y7.95%
PM growth 5Y8.57%
GM growth 3Y-0.19%
GM growth 5Y0.34%
MANH Yearly Profit, Operating, Gross MarginsMANH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MANH is creating value.
The number of shares outstanding for MANH has been reduced compared to 1 year ago.
MANH has less shares outstanding than it did 5 years ago.
MANH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MANH Yearly Shares OutstandingMANH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MANH Yearly Total Debt VS Total AssetsMANH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

MANH has an Altman-Z score of 17.09. This indicates that MANH is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of MANH (17.09) is better than 92.86% of its industry peers.
MANH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 17.09
ROIC/WACC5.62
WACC10.97%
MANH Yearly LT Debt VS Equity VS FCFMANH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.3 Liquidity

MANH has a Current Ratio of 1.31. This is a normal value and indicates that MANH is financially healthy and should not expect problems in meeting its short term obligations.
MANH has a Current ratio (1.31) which is comparable to the rest of the industry.
MANH has a Quick Ratio of 1.31. This is a normal value and indicates that MANH is financially healthy and should not expect problems in meeting its short term obligations.
MANH's Quick ratio of 1.31 is in line compared to the rest of the industry. MANH outperforms 41.43% of its industry peers.
The current and quick ratio evaluation for MANH is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
MANH Yearly Current Assets VS Current LiabilitesMANH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

MANH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.59%, which is quite good.
MANH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.14% yearly.
Looking at the last year, MANH shows a small growth in Revenue. The Revenue has grown by 4.10% in the last year.
Measured over the past years, MANH shows a quite strong growth in Revenue. The Revenue has been growing by 11.02% on average per year.
EPS 1Y (TTM)9.59%
EPS 3Y28.48%
EPS 5Y22.14%
EPS Q2Q%0.74%
Revenue 1Y (TTM)4.1%
Revenue growth 3Y16.24%
Revenue growth 5Y11.02%
Sales Q2Q%3.42%

3.2 Future

Based on estimates for the next years, MANH will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.35% on average per year.
MANH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.70% yearly.
EPS Next Y7.11%
EPS Next 2Y7.51%
EPS Next 3Y10%
EPS Next 5Y17.35%
Revenue Next Year3.58%
Revenue Next 2Y5.11%
Revenue Next 3Y6.4%
Revenue Next 5Y7.7%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MANH Yearly Revenue VS EstimatesMANH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
MANH Yearly EPS VS EstimatesMANH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 34.77 indicates a quite expensive valuation of MANH.
Based on the Price/Earnings ratio, MANH is valued a bit cheaper than the industry average as 60.36% of the companies are valued more expensively.
MANH is valuated rather expensively when we compare the Price/Earnings ratio to 26.59, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 31.98, MANH can be considered very expensive at the moment.
MANH's Price/Forward Earnings ratio is in line with the industry average.
MANH is valuated rather expensively when we compare the Price/Forward Earnings ratio to 23.80, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 34.77
Fwd PE 31.98
MANH Price Earnings VS Forward Price EarningsMANH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MANH is valued a bit cheaper than 66.43% of the companies in the same industry.
70.00% of the companies in the same industry are more expensive than MANH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 31.63
EV/EBITDA 36.19
MANH Per share dataMANH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MANH does not grow enough to justify the current Price/Earnings ratio.
MANH has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)4.89
PEG (5Y)1.57
EPS Next 2Y7.51%
EPS Next 3Y10%

0

5. Dividend

5.1 Amount

MANH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MANHATTAN ASSOCIATES INC

NASDAQ:MANH (12/10/2025, 7:02:33 PM)

After market: 174.87 0 (0%)

174.87

+0.63 (+0.36%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-21 2025-10-21/amc
Earnings (Next)01-26 2026-01-26/amc
Inst Owners104.28%
Inst Owner Change2.02%
Ins Owners1.21%
Ins Owner Change-5.64%
Market Cap10.54B
Revenue(TTM)1.07B
Net Income(TTM)216.01M
Analysts81.05
Price Target230.44 (31.78%)
Short Float %3.33%
Short Ratio3.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.65%
Min EPS beat(2)13.36%
Max EPS beat(2)13.93%
EPS beat(4)4
Avg EPS beat(4)12.31%
Min EPS beat(4)8.28%
Max EPS beat(4)13.93%
EPS beat(8)8
Avg EPS beat(8)17.09%
EPS beat(12)12
Avg EPS beat(12)22.76%
EPS beat(16)16
Avg EPS beat(16)22.85%
Revenue beat(2)1
Avg Revenue beat(2)0.38%
Min Revenue beat(2)-0.51%
Max Revenue beat(2)1.26%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.93%
Max Revenue beat(4)1.26%
Revenue beat(8)5
Avg Revenue beat(8)1.01%
Revenue beat(12)9
Avg Revenue beat(12)2.52%
Revenue beat(16)13
Avg Revenue beat(16)2.9%
PT rev (1m)-0.2%
PT rev (3m)-1.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.4%
EPS NY rev (1m)0%
EPS NY rev (3m)3.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.72%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.18%
Valuation
Industry RankSector Rank
PE 34.77
Fwd PE 31.98
P/S 9.88
P/FCF 31.63
P/OCF 30.36
P/B 34.08
P/tB 42.67
EV/EBITDA 36.19
EPS(TTM)5.03
EY2.88%
EPS(NY)5.47
Fwd EY3.13%
FCF(TTM)5.53
FCFY3.16%
OCF(TTM)5.76
OCFY3.29%
SpS17.7
BVpS5.13
TBVpS4.1
PEG (NY)4.89
PEG (5Y)1.57
Graham Number24.1
Profitability
Industry RankSector Rank
ROA 28.1%
ROE 69.86%
ROCE 75.03%
ROIC 61.7%
ROICexc 216.78%
ROICexgc 533.41%
OM 25.91%
PM (TTM) 20.25%
GM 56.54%
FCFM 31.23%
ROA(3y)25.89%
ROA(5y)23.38%
ROE(3y)64.44%
ROE(5y)55.45%
ROIC(3y)55.23%
ROIC(5y)47.73%
ROICexc(3y)379.42%
ROICexc(5y)338.92%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)67.16%
ROCE(5y)58.04%
ROICexgc growth 3YN/A
ROICexgc growth 5Y6.89%
ROICexc growth 3Y-16.71%
ROICexc growth 5Y14.68%
OM growth 3Y7.44%
OM growth 5Y6%
PM growth 3Y7.95%
PM growth 5Y8.57%
GM growth 3Y-0.19%
GM growth 5Y0.34%
F-Score7
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 217.07%
Cap/Sales 1.31%
Interest Coverage 250
Cash Conversion 122.73%
Profit Quality 154.25%
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 17.09
F-Score7
WACC10.97%
ROIC/WACC5.62
Cap/Depr(3y)106.14%
Cap/Depr(5y)79.88%
Cap/Sales(3y)0.73%
Cap/Sales(5y)0.65%
Profit Quality(3y)134%
Profit Quality(5y)144.89%
High Growth Momentum
Growth
EPS 1Y (TTM)9.59%
EPS 3Y28.48%
EPS 5Y22.14%
EPS Q2Q%0.74%
EPS Next Y7.11%
EPS Next 2Y7.51%
EPS Next 3Y10%
EPS Next 5Y17.35%
Revenue 1Y (TTM)4.1%
Revenue growth 3Y16.24%
Revenue growth 5Y11.02%
Sales Q2Q%3.42%
Revenue Next Year3.58%
Revenue Next 2Y5.11%
Revenue Next 3Y6.4%
Revenue Next 5Y7.7%
EBIT growth 1Y6.41%
EBIT growth 3Y24.89%
EBIT growth 5Y17.68%
EBIT Next Year10.56%
EBIT Next 3Y9.47%
EBIT Next 5Y11.24%
FCF growth 1Y60.27%
FCF growth 3Y16.48%
FCF growth 5Y16.8%
OCF growth 1Y62.89%
OCF growth 3Y16.79%
OCF growth 5Y14.96%

MANHATTAN ASSOCIATES INC / MANH FAQ

Can you provide the ChartMill fundamental rating for MANHATTAN ASSOCIATES INC?

ChartMill assigns a fundamental rating of 7 / 10 to MANH.


What is the valuation status of MANHATTAN ASSOCIATES INC (MANH) stock?

ChartMill assigns a valuation rating of 3 / 10 to MANHATTAN ASSOCIATES INC (MANH). This can be considered as Overvalued.


Can you provide the profitability details for MANHATTAN ASSOCIATES INC?

MANHATTAN ASSOCIATES INC (MANH) has a profitability rating of 9 / 10.


Can you provide the PE and PB ratios for MANH stock?

The Price/Earnings (PE) ratio for MANHATTAN ASSOCIATES INC (MANH) is 34.77 and the Price/Book (PB) ratio is 34.08.


Can you provide the financial health for MANH stock?

The financial health rating of MANHATTAN ASSOCIATES INC (MANH) is 9 / 10.